123 related articles for article (PubMed ID: 19418647)
1. Lamivudine/zidovudine: paediatric indication. For certain HIV-infected children.
Prescrire Int; 2008 Dec; 17(98):228. PubMed ID: 19418647
[TBL] [Abstract][Full Text] [Related]
2. FDA notifications. Lamivudine/zidovudine combination approved for pediatric use.
AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19938311
[No Abstract] [Full Text] [Related]
3. Lamivudine 300 mg in HIV infection: dose change. Once-a-day dosing.
Prescrire Int; 2004 Apr; 13(70):54. PubMed ID: 15148972
[TBL] [Abstract][Full Text] [Related]
4. [Lamivudine-zidovudine combination treatment].
Mörike EM
Dtsch Med Wochenschr; 1996 Oct; 121(40):A8, A11. PubMed ID: 8925752
[No Abstract] [Full Text] [Related]
5. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
Hester EK; Peacock JE
AIDS; 1998 Mar; 12(4):439-40. PubMed ID: 9520175
[No Abstract] [Full Text] [Related]
6. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
7. Copackaged drug regimen approved for PEPFAR.
AIDS Alert; 2005 Apr; 20(4):46. PubMed ID: 15841530
[No Abstract] [Full Text] [Related]
8. HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish?
Cohen MS
Sex Transm Dis; 2008 Dec; 35(12):979-80. PubMed ID: 18955917
[No Abstract] [Full Text] [Related]
9. FDA notifications. FDA approval for generic lamivudine/zidovudine.
AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
[No Abstract] [Full Text] [Related]
10. FDA notifications. Tentative approval for generic lamivudine/zidovudine.
AIDS Alert; 2007 Oct; 22(10):119-20. PubMed ID: 18416011
[No Abstract] [Full Text] [Related]
11. Negligence. Liver transplant patient too late to sue Viramune maker.
AIDS Policy Law; 2003 Mar; 18(6):7. PubMed ID: 12712930
[No Abstract] [Full Text] [Related]
12. Geotrichum proctitis after HIV postexposure prophylaxis.
Yánez L; Hernández JL; Saiz N; Calvo J; Ramos C; Salesa R; González-Macías J
AIDS; 2002 Aug; 16(12):1701-2. PubMed ID: 12172101
[No Abstract] [Full Text] [Related]
13. First combination drug for patients with HIV.
Am Fam Physician; 1997 Dec; 56(9):2356. PubMed ID: 9402816
[No Abstract] [Full Text] [Related]
14. Switching Combivir to Truvada keeps HIV undetectable, improves blood fats, fails to improve limb fat.
Proj Inf Perspect; 2008 Dec; (47):8. PubMed ID: 19227559
[No Abstract] [Full Text] [Related]
15. FDA notifications. Generic lamivudine/zidovudine approved.
AIDS Alert; 2009 Jul; 24(7):82. PubMed ID: 19705578
[No Abstract] [Full Text] [Related]
16. Wheel keeps turning for antiviral combination chemotherapy.
Coen DM
Trends Microbiol; 1996 Feb; 4(2):51-2. PubMed ID: 8820566
[No Abstract] [Full Text] [Related]
17. Neurological disorders after zidovudine exposure in utero.
Prescrire Int; 1999 Dec; 8(44):181-2. PubMed ID: 11503820
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of fosamprenavir/ritonavir associated with zidovudine-lamivudine used as postexposure prophylaxis for HIV infection.
Burty C; Pavel S; Ghomari K; Vermersch A; Christian B; Pouaha J; Yazdanpanah Y; May T; Rabaud C
J Acquir Immune Defic Syndr; 2008 Nov; 49(3):334-6. PubMed ID: 18978479
[No Abstract] [Full Text] [Related]
19. FDA notifications. Generic zidovudine oral solution approved.
AIDS Alert; 2008 Aug; 23(8):90. PubMed ID: 18724489
[No Abstract] [Full Text] [Related]
20. Epivir for younger children.
Vazquez E
Posit Aware; 1999; 10(3):26. PubMed ID: 11366765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
